Skip to content

Study · Animal study (in vivo) · rat · 2008

9 results

GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia.

Granado M, Martín AI, López-Menduiña M, López-Calderón A, Villanúa MA

American journal of physiology. Endocrinology and metabolism6 Nov 2007Cited by 32 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study9

9 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In Wistar rats given LPS, GHRP‑2 attenuated the LPS-induced increase in serum transaminases.

    In plain wordsIn rats given a bacterial toxin, GHRP‑2 reduced the rise in blood liver enzymes.

    Peptide
    GHRP-2
    Outcome
    DecreaseSerum transaminases in LPS-treated rats
    Study

    ratn: not reported in source

    LPS-induced endotoxemia
    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    100 microg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    GHRP-2 administration attenuated the effects of LPS on transaminases, nitrites/nitrates, TNF-alpha, and IGF-I in vivo.
    2 context sentences
    Summary · context
    LPS increased serum levels of transaminases and nitrites/nitrates.
    Summary · context
    Wistar rats were simultaneously injected (ip) with LPS (1 mg/kg) and/or GHRP-2 (100 microg/kg).
  2. 02AnimalAnimal study (in vivo)Mechanism

    In Wistar rats given LPS, GHRP‑2 attenuated the LPS-induced increase in circulating nitrites/nitrates.

    In plain wordsIn rats given a bacterial toxin, GHRP‑2 reduced the rise in blood nitric oxide products.

    Peptide
    GHRP-2
    Outcome
    DecreaseCirculating nitrites/nitrates in LPS-treated rats
    Study

    ratn: not reported in source

    LPS-induced endotoxemia
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    100 microg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    GHRP-2 administration attenuated the effects of LPS on transaminases, nitrites/nitrates, TNF-alpha, and IGF-I in vivo.
    2 context sentences
    Summary · context
    LPS increased serum levels of transaminases and nitrites/nitrates.
    Summary · context
    Wistar rats were simultaneously injected (ip) with LPS (1 mg/kg) and/or GHRP-2 (100 microg/kg).
  3. 03AnimalAnimal study (in vivo)Mechanism

    In Wistar rats given LPS, GHRP‑2 attenuated the LPS-induced increase in hepatic TNF-alpha mRNA.

    In plain wordsIn rats given a bacterial toxin, GHRP‑2 reduced the rise in liver TNF-alpha gene activity.

    Peptide
    GHRP-2
    Outcome
    DecreaseHepatic TNF-alpha mRNA in LPS-treated rats
    Study

    ratn: not reported in source

    LPS-induced endotoxemia
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    100 microg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    GHRP-2 administration attenuated the effects of LPS on transaminases, nitrites/nitrates, TNF-alpha, and IGF-I in vivo.
    2 context sentences
    Summary · context
    Moreover, LPS increased hepatic TNF-alpha and decreased hepatic IGF-I mRNAs.
    Summary · context
    Wistar rats were simultaneously injected (ip) with LPS (1 mg/kg) and/or GHRP-2 (100 microg/kg).
  4. 04AnimalAnimal study (in vivo)Mechanism

    In Wistar rats given LPS, GHRP‑2 attenuated the LPS-induced decrease in hepatic IGF-I mRNA.

    In plain wordsIn rats given a bacterial toxin, GHRP‑2 reduced the fall in liver IGF-I gene activity.

    Peptide
    GHRP-2
    Outcome
    IncreaseHepatic IGF-I mRNA in LPS-treated rats
    Study

    ratn: not reported in source

    LPS-induced endotoxemia
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    100 microg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    GHRP-2 administration attenuated the effects of LPS on transaminases, nitrites/nitrates, TNF-alpha, and IGF-I in vivo.
    2 context sentences
    Summary · context
    Moreover, LPS increased hepatic TNF-alpha and decreased hepatic IGF-I mRNAs.
    Summary · context
    Wistar rats were simultaneously injected (ip) with LPS (1 mg/kg) and/or GHRP-2 (100 microg/kg).
  5. 05LabIn vitro (cells)Efficacy outcome

    In cocultures of hepatocytes and nonparenchymal cells, GHRP‑2 prevented the endotoxin-induced increase in transaminases.

    In plain wordsIn lab-grown liver cell mixtures, GHRP‑2 prevented the rise in liver enzymes caused by a bacterial toxin.

    Peptide
    GHRP-2
    Outcome
    DecreaseEndotoxin-induced transaminase increase in cocultures
    Study

    n: not reported in source

    cocultures of hepatocytes and nonparenchymal cells
    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The ghrelin receptor agonist prevented an endotoxin-induced increase in transaminases and nitrite/nitrate release as well as in TNF-alpha mRNA and increased IGF-I mRNA from cocultures of hepatocytes and nonparenchymal cells, but not from monocultures.
    1 context sentence
    Summary · context
    To elucidate whether GHRP-2 is acting directly on the liver, cocultures of hepatocytes and nonparenchymal cells and monocultures of isolated hepatocytes were incubated with LPS and GHRP-2.
  6. 06LabIn vitro (cells)Mechanism

    In cocultures of hepatocytes and nonparenchymal cells, GHRP‑2 prevented the endotoxin-induced increase in nitrite/nitrate release.

    In plain wordsIn lab-grown liver cell mixtures, GHRP‑2 prevented the rise in nitric oxide products caused by a bacterial toxin.

    Peptide
    GHRP-2
    Outcome
    DecreaseEndotoxin-induced nitrite/nitrate release in cocultures
    Study

    n: not reported in source

    cocultures of hepatocytes and nonparenchymal cells
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The ghrelin receptor agonist prevented an endotoxin-induced increase in transaminases and nitrite/nitrate release as well as in TNF-alpha mRNA and increased IGF-I mRNA from cocultures of hepatocytes and nonparenchymal cells, but not from monocultures.
    1 context sentence
    Summary · context
    To elucidate whether GHRP-2 is acting directly on the liver, cocultures of hepatocytes and nonparenchymal cells and monocultures of isolated hepatocytes were incubated with LPS and GHRP-2.
  7. 07LabIn vitro (cells)Mechanism

    In cocultures of hepatocytes and nonparenchymal cells, GHRP‑2 prevented the endotoxin-induced increase in TNF-alpha mRNA.

    In plain wordsIn lab-grown liver cell mixtures, GHRP‑2 prevented the rise in TNF-alpha gene activity caused by a bacterial toxin.

    Peptide
    GHRP-2
    Outcome
    DecreaseEndotoxin-induced TNF-alpha mRNA in cocultures
    Study

    n: not reported in source

    cocultures of hepatocytes and nonparenchymal cells
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The ghrelin receptor agonist prevented an endotoxin-induced increase in transaminases and nitrite/nitrate release as well as in TNF-alpha mRNA and increased IGF-I mRNA from cocultures of hepatocytes and nonparenchymal cells, but not from monocultures.
    1 context sentence
    Summary · context
    To elucidate whether GHRP-2 is acting directly on the liver, cocultures of hepatocytes and nonparenchymal cells and monocultures of isolated hepatocytes were incubated with LPS and GHRP-2.
  8. 08LabIn vitro (cells)Mechanism

    In cocultures of hepatocytes and nonparenchymal cells, GHRP‑2 increased IGF-I mRNA.

    In plain wordsIn lab-grown liver cell mixtures, GHRP‑2 raised IGF-I gene activity.

    Peptide
    GHRP-2
    Outcome
    IncreaseIGF-I mRNA in cocultures
    Study

    n: not reported in source

    cocultures of hepatocytes and nonparenchymal cells
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The ghrelin receptor agonist prevented an endotoxin-induced increase in transaminases and nitrite/nitrate release as well as in TNF-alpha mRNA and increased IGF-I mRNA from cocultures of hepatocytes and nonparenchymal cells, but not from monocultures.
    1 context sentence
    Summary · context
    To elucidate whether GHRP-2 is acting directly on the liver, cocultures of hepatocytes and nonparenchymal cells and monocultures of isolated hepatocytes were incubated with LPS and GHRP-2.
  9. 09LabIn vitro (cells)Mechanism

    In monocultures of isolated hepatocytes, GHRP‑2 did not produce the effects seen in cocultures (transaminases, nitrite/nitrate, TNF-alpha mRNA, IGF-I mRNA).

    In plain wordsIn lab-grown liver cells alone, GHRP‑2 did not show the protective effects seen in mixed liver cell cultures.

    Peptide
    GHRP-2
    Outcome
    No significant changeGHRP-2 effects on endotoxin-induced changes in hepatocyte monocultures
    Study

    n: not reported in source

    monocultures of isolated hepatocytes
    Outcome group
    Inflammation markers · Liver
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The ghrelin receptor agonist prevented an endotoxin-induced increase in transaminases and nitrite/nitrate release as well as in TNF-alpha mRNA and increased IGF-I mRNA from cocultures of hepatocytes and nonparenchymal cells, but not from monocultures.
    1 context sentence
    Summary · context
    To elucidate whether GHRP-2 is acting directly on the liver, cocultures of hepatocytes and nonparenchymal cells and monocultures of isolated hepatocytes were incubated with LPS and GHRP-2.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.